RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
-2.4%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$1.42B
AUM Growth
+$1.42B
(-3.3%)
Cap. Flow
+$25.4M
Cap. Flow
% of AUM
1.79%
Top 10 Holdings %
Top 10 Hldgs %
29.29%
Holding
97
New
3
Increased
35
Reduced
20
Closed
5
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$31.5M |
| 2 |
Pfizer
PFE
|
$21.5M |
| 3 |
Biogen
BIIB
|
$17M |
| 4 |
McKesson
MCK
|
$14M |
| 5 |
Elevance Health
ELV
|
$9.32M |
Top Sells
Sector Composition
| 1 | Healthcare | 96.82% |
| 2 | Industrials | 1.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Intuitive Surgical
ISRG
$158B
| $19.9M | 1.4% |
20,000
-2,500
| -11% | -$2.49M |
|
27
Teladoc Health
TDOC
$1.37B
| $19M | 1.34% |
150,000
-60,000
| -29% | -$7.61M |
|
28
Alnylam Pharmaceuticals
ALNY
$58.6B
| $18.9M | 1.33% |
100,000
-35,000
| -26% | -$6.61M |
|
|
AXNX
29
DELISTED
Axonics, Inc. Common Stock
AXNX
| $18.9M | 1.32% |
290,000
-90,000
| -24% | -$5.86M |
|
|
BHVN
30
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $18.8M | 1.32% |
135,000
-65,419
| -33% | -$9.09M |
|
31
Centene
CNC
$14.8B
| $18.7M | 1.31% |
300,000
+40,000
| +15% | +$2.49M |
|
32
Cooper Companies
COO
$13.3B
| $18.6M | 1.31% |
45,000
| – | – |
|
33
BioMarin Pharmaceuticals
BMRN
$11.3B
| $18.6M | 1.3% |
240,000
+80,000
| +50% | +$6.18M |
|
34
Apellis Pharmaceuticals
APLS
$3.51B
| $18.5M | 1.3% |
561,269
+256,269
| +84% | +$8.45M |
|
35
HCA Healthcare
HCA
$95.4B
| $18.2M | 1.28% |
75,000
| – | – |
|
36
Zimmer Biomet
ZBH
$20.8B
| $17.6M | 1.23% |
120,000
-20,000
| -14% | -$2.93M |
|
37
Veeva Systems
VEEV
$44.4B
| $17.3M | 1.21% |
60,000
-15,000
| -20% | -$4.32M |
|
38
Exact Sciences
EXAS
$9.33B
| $17.2M | 1.21% |
180,000
+25,000
| +16% | +$2.39M |
|
39
Nektar Therapeutics
NKTR
$543M
| $17.1M | 1.2% |
950,000
| – | – |
|
40
Xencor
XNCR
$594M
| $16.6M | 1.16% |
507,002
+167,002
| +49% | +$5.45M |
|
|
ITCI
41
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $16M | 1.12% |
429,728
| – | – |
|
42
Dynavax Technologies
DVAX
$1.19B
| $14.4M | 1.01% |
750,000
| – | – |
|
43
Becton Dickinson
BDX
$54.3B
| $14.3M | 1% |
58,000
+10,000
| +21% | +$2.46M |
|
|
ACCD
44
DELISTED
Accolade, Inc. Common Stock
ACCD
| $13.7M | 0.96% |
325,000
+25,000
| +8% | +$1.05M |
|
|
RCM
45
DELISTED
R1 RCM Inc. Common Stock
RCM
| $12.1M | 0.85% |
550,000
| – | – |
|
46
Health Catalyst
HCAT
$228M
| $12M | 0.84% |
240,000
| – | – |
|
47
Tenet Healthcare
THC
$16.5B
| $12M | 0.84% |
180,000
+95,000
| +112% | +$6.31M |
|
48
Edwards Lifesciences
EW
$47.7B
| $11.9M | 0.83% |
105,000
-5,000
| -5% | -$566K |
|
49
MacroGenics
MGNX
$121M
| $11.4M | 0.8% |
545,160
| – | – |
|
50
Neurocrine Biosciences
NBIX
$13.5B
| $9.11M | 0.64% |
95,000
-10,000
| -10% | -$959K |
|